1. Home
  2. ARWR vs YUMC Comparison

ARWR vs YUMC Comparison

Compare ARWR & YUMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

N/A

Current Price

$59.98

Market Cap

12.4B

Sector

Health Care

ML Signal

N/A

Logo Yum China Holdings Inc.

YUMC

Yum China Holdings Inc.

N/A

Current Price

$47.21

Market Cap

14.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
ARWR
YUMC
Founded
2003
1987
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.4B
14.8B
IPO Year
2009
2016

Fundamental Metrics

Financial Performance
Metric
ARWR
YUMC
Price
$59.98
$47.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
20
Target Price
★ $107.71
$62.07
AVG Volume (30 Days)
★ 1.7M
1.6M
Earning Date
11-24-2026
11-03-2026
Dividend Yield
N/A
★ 2.53%
EPS Growth
★ 99.80
7.73
EPS
N/A
★ 1.57
Revenue
$16,142,321.00
★ $11,797,000,000.00
Revenue This Year
N/A
$9.22
Revenue Next Year
N/A
$6.15
P/E Ratio
★ N/A
$29.11
Revenue Growth
N/A
★ 4.37
52 Week Low
$37.06
$39.72
52 Week High
$95.49
$58.39

Technical Indicators

Market Signals
Indicator
ARWR
YUMC
Relative Strength Index (RSI) 42.08 70.27
Support Level $54.93 $42.45
Resistance Level $66.37 $49.90
Average True Range (ATR) 2.22 0.73
MACD 0.91 0.26
Stochastic Oscillator 71.90 97.37

Price Performance

Historical Comparison
ARWR
YUMC

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

About YUMC Yum China Holdings Inc.

Yum China is the largest restaurant operator in China, with over 18,000 locations and USD 12 billion in systemwide sales as of 2025. It generates revenue primarily from its own restaurants and franchise fees. While KFC and Pizza Hut are its flagship brands, Yum China's portfolio also includes Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza.As a trademark licensee of Yum Brands, Yum China pays 3% of KFC and Pizza Hut's systemwide sales to its former parent, from which it spun off in 2016. However, even before the separation, Yum China was granted substantial autonomy, giving its Chinese leadership decision-making authority over menu, supply chain, and marketing—an unusual practice for Western chains at the time.

Share on Social Networks: